Quarterly report pursuant to Section 13 or 15(d)

Condensed Interim Consolidated Balance Sheets

v3.7.0.1
Condensed Interim Consolidated Balance Sheets - USD ($)
Mar. 31, 2017
Sep. 30, 2016
Current assets:    
Cash and cash equivalents $ 4,601,222 $ 7,416,904
Accounts receivable 65,881 85,813
Short-term investments 3,994,364 3,988,794
Inventory 310,574 249,430
Prepaid expenses 376,643 358,714
Total current assets 9,348,684 12,099,655
Noncurrent assets:    
Equity investment in joint venture 66,695 66,695
Property, plant and equipment, net 792,270 756,114
Deposits 15,340 15,340
Total noncurrent assets 874,305 838,149
Total Assets 10,222,989 12,937,804
Current liabilities:    
Accounts payable and accrued liabilities 433,384 623,644
Total Current Liabilities 433,384 623,644
Commitments (Note 7)
Shareholders' equity:    
Common shares, unlimited common shares authorized, no par value, 10,136,258 issued and outstanding at March 31, 2017 and September 30, 2016 47,280,792 47,280,792
Accumulated share-based compensation 5,459,557 5,394,763
Accumulated deficit (42,950,744) (40,361,395)
Total Shareholders' Equity 9,789,605 12,314,160
Total Liabilities and Shareholders' Equity $ 10,222,989 $ 12,937,804